Drug trio improved effectiveness of cancer treatment, protected heart

Abstract 16494

2012-11-06

(Press-News.org) Combining cancer medication with a drug for erectile dysfunction and one for heart transplants helped kill cancer cells and protected the heart from damage, in a study presented at the American Heart Association's Scientific Sessions 2012. For decades, doxorubicin has been a powerful anti-cancer treatment for various human cancers, including breast, ovarian, colon and prostate. But its use has been limited due to harmful, possibly irreversible effects on the heart. In this study, using cell and animal models, researchers found that sildenafil alone or in combination with rapamycin (an immunosuppressant used to prevent post-transplant organ rejection) significantly improved the anti-cancer effects of doxorubicin while protecting the heart. The combination of all three medications showed the most powerful effect, researchers said. "Because sildenafil and rapamycin are clinically approved drugs that both protect heart muscle, we thought that combining these drugs with doxorubicin would be a unique strategy to eliminate the cardiac side effects of doxorubicin while further improving its cancer-killing ability," said Rakesh Kukreja, Ph.D., study co-author and professor of internal medicine and cardiology, Virginia Commonwealth University (VCU) School of Medicine in Richmond. "The drug combination led to a dramatic protection of heart muscle from apoptosis (cellular self-destruction) and, to a lesser extent, necrosis (cell death from disease)," said David E. Durrant, study lead author and Ph.D. candidate at the VCU School of Medicine. "We think this combination therapy may have excellent potential to move forward into clinical trials and eventually improve life expectancy of cancer patients." More research is needed to understand how sildenafil and rapamycin work together to improve doxorubicin treatment, Durrant said. ### Co-authors are Anindita Das, Ph.D. and Fadi Salloum, Ph.D. Author disclosures are on the abstract. The National Institutes of Health funded the study. Read more about other research using rapamycin. Follow news from the American Heart Association's Scientific Sessions 2012 via Twitter: @HeartNews.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.

Note: Actual presentation is 9 a.m. PT/ 12 noon ET, Wednesday, Nov. 7, 2012 in Room 515a.

All downloadable video/audio interviews, B-roll, animation and images related to this news release are located on the right column of the release link located at http://newsroom.heart.org/pr/aha/_prv-drug-trio-improved-effectiveness-239566.aspx. Video clips with researchers/authors of studies will be added to the release links after embargo. General B-roll and Photos

ELSE PRESS RELEASES FROM THIS DATE:

2011 Virginia quake triggered landslides at extraordinary distances

2012-11-06

The 2011 Mineral, Virginia M-5.8 earthquake was felt over an extraordinarily large area. A new study details landslides triggered by the earthquake at distances four times greater and over an area 20 times larger than previously documented for M-5.8 earthquakes worldwide. The study, to be published in the December issue of the Bulletin of the Seismological Society of America (BSSA), describes physical confirmation of previous observations that ground shaking from earthquakes in the eastern U.S. travels farther than in the western U.S, a plate-boundary region. U.S. ...

Surprising findings from NHLBI Exome Sequencing Project reported

2012-11-06

A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken. Scientists participating in the project initially expected that individual rare variants would have a greater effect on over 80 heart, lung and blood related traits and diseases of high public health significance, said Suzanne M. Leal, Ph.D., professor and director, Center ...

New study finds that 75 percent of patients taking popular blood-thinners are getting wrong dose

2012-11-06

SALT LAKE CITY – Cardiology researchers at the Intermountain Medical Center Heart Institute have found that approximately 75 percent of patients taking two common blood-thinning drugs may be receiving the wrong dosage levels, according to a new study. This could put them at risk for serious problems like uncontrolled bleeding or developing blood clots. Millions of Americans with coronary artery disease take one of the two drugs — clopidogrel (Plavix) and prasugrel (Effient) — to prevent harmful blood clots that can cause a stroke or heart attack. Current guidelines ...

Researchers discover immune pathway

2012-11-06

Researchers from Aarhus University, Denmark, have now discovered an important mechanism behind one of our most fundamental lines of immune function. The discovery has been published in the esteemed scientific journal, The Journal of Immunology, where it has been highlighted as a top story. In collaboration with colleagues from USA and Turkey, they have discovered exactly which enzymes collaborate in the first line of the immune defence. Thus, they answer a central question about the so-called complement system, which has been a focal point of the scientific field for the ...

Clever cockatoo with skilled craftmanship

2012-11-06

VIDEO: Figaro, a Goffin's Cockatoo, makes and uses a tool. Click here for more information. Goffin's cockatoos are a highly playful and curious Indonesian cockatoo species. Therefore, cognitive biologists are now using them as a model species to investigate intelligent behaviour in birds. Together with researchers from the University of Oxford, Alice Auersperg and Birgit Szabo from the Department of Cognitive Biology at the University of Vienna have made a sensational discovery: ...

A new computational method for timing the tree of life

2012-11-06

With its deeply embedded roots, sturdy trunk and dense profusion of branches, the Tree of Life is a structure of nearly unfathomable complexity and beauty. While major strides have been made to establish the evolutionary hierarchy encompassing every living species, the project is still in its infancy. At Arizona State University's Biodesign Institute, Sudhir Kumar has been filling in the Tree of Life by developing sophisticated methods and bioinformatics tools. His latest research, which appeared on the advance online edition of the Proceedings of the National Academy ...

A new development in the relief of spasms related to amyotrophic lateral sclerosis

2012-11-06

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an occurrence rate in France similar to multiple sclerosis (two to three new cases per year for every 100,000 residents). It has a specific affect on neurons responsible for motor control, in particular motor neurones and central motor neurones. The former, located in the spinal cord, are directly linked to muscles and are used for muscle contraction and stretching. The latter, located in the brain, receive movement orders. As the disease develops, the neurons degenerate and the muscles are no longer ...

Pressure switch inside the head

2012-11-06

To this day it remains a mystery why the cerebral pressure in certain people suddenly increases. The consequences, however, are better understood: The blood circulation is disrupted and after a while parts of the brain may die off, similar to what occurs in a stroke. This is how dementia takes its insidious path. Experts estimate that up to ten percent of all cases of dementia in Europe can be attributed to rising blood pressure in the brain. Still, making the diagnosis is tough. People with a heightened susceptibility to a rise in intracranial pressure must be treated ...

Quality products from rubber residues

2012-11-06

Each year throughout the world, up to 22 million tons of rubber are processed and a large portion of it goes into the production of vehicle tires. Once the products reach the end of their useful life, they typically land in the incinerator. In the best case, the waste rubber is recycled into secondary products. Ground to powder, the rubber residues can be found, for example, in the floor coverings used at sports arenas and playgrounds, and in doormats. But until now, the appropriate techniques for producing high-quality materials from these recyclables did not exist. Researchers ...

Long shifts lead to nurse burnout and dissatisfied patients

2012-11-06

Extended work shifts of twelve hours or longer are common and popular among hospital staff nurses, but a new study reports that nurses working longer shifts were more likely to experience burnout, job dissatisfaction, and patients were more dissatisfied with their care. In the first study to examine the relationship between nurse shift length and patients' assessment of care, researchers from the University of Pennsylvania School of Nursing report that nurses working shifts of ten hours or longer were up to two and a half times more likely than nurses working shorter ...

Drug trio improved effectiveness of cancer treatment, protected heart

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: